#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary fibrosis Acute respiratory distress syndrome Leber's congenital amaurosis Retinitis pigmentosa Glomerulonephritis minimal lesion Pulmonary sarcoidosis Renal cancer metastatic Bronchopulmonary dysplasia Huntington's disease Neuropathy peripheral Severe myoclonic epilepsy of infancy Spinal muscular atrophy Raynaud's phenomenon Cervix carcinoma Barth syndrome More trials…

    Learn about Rare Diseases

    Sarcoma – Trials in Disease Lymphangiosarcoma – Treatment Cystic fibrosis – Life with Disease Friedreich’s ataxia – Basic Information Proteus syndrome – Trials in Disease Nodal marginal zone B-cell lymphoma Nephroblastoma – Treatment Ornithine transcarbamoylase deficiency – Diagnostics Hereditary ataxia – Diagnostics Phenylketonuria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZIGAKIBART CAMOSTAT MESILATE Sufentanil Human Normal Immunoglobulin L-Tryptophan Int-787 PALAZESTRANT L-Lysine Hydrochloride AAV9-CTNT-COBAG3 Amiloride Hydrochloride Gns561 RPTR-1-201 Cat Epithelium Extract Ampicillin Adagrasib DUVELISIB Carbamazepine (Ph. Eur.) Domperidone Rmc-6291 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Diabetic retinal oedema Tumour thrombosis Autoimmune disorder Obstructive airways disorder Penile squamous cell carcinoma Arthralgia Ependymoma malignant Pyelonephritis Endolymphatic hydrops Meningioma Bladder cancer Epicondylitis Ischaemic skin ulcer Thalassaemia Hepato-lenticular degeneration More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic obstructive pulmonary disease

  • Study on Budesonide for COPD Patients with Different Eosinophil Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Budesonide
    Germany The Netherlands Spain

  • Study on Oxygen Therapy and Drug Combination for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Air, Medicinal
    • Fenoterol Hydrobromide
    • Ipratropium Bromide
    Denmark

  • A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Belgium Bulgaria Denmark France Germany Greece +6

  • Study of dupilumab added to standard care in adults hospitalized for COPD exacerbation to reduce readmissions, emergency visits, and death

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Dupilumab
    Belgium Italy

  • Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Bulgaria Czechia France Germany Greece Hungary +3

  • Study of the effect of lyophilized bacterial lysates on reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD)

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Hungary
Previous Page
1 2 3 4 5 6 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!